Cargando…
The value of PET, CT and in-line PET/CT in patients with gastrointestinal stromal tumours: long-term outcome of treatment with imatinib mesylate
PURPOSE: Gastrointestinal stromal tumours (GIST) are mesenchymal neoplasms of the gastrointestinal tract that are unresponsive to standard sarcoma chemotherapy. Imaging of GIST patients is done with structural and functional methods such as contrast-enhanced helical computed tomography (ceCT) and po...
Autores principales: | Goerres, G. W., Stupp, R., Barghouth, G., Hany, T. F., Pestalozzi, B., Dizendorf, E., Schnyder, P., Luthi, F., von Schulthess, G. K., Leyvraz, S. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2706372/ https://www.ncbi.nlm.nih.gov/pubmed/15690223 http://dx.doi.org/10.1007/s00259-004-1633-7 |
Ejemplares similares
-
Clinical molecular anatomic imaging: PET, PET/CT, and Spect/CT
por: Von Schulthess, Gustav K
Publicado: (2003) -
Treatment of gastrointestinal stromal tumor: focus on imatinib mesylate
por: Din, Omar S, et al.
Publicado: (2008) -
ZNF-Mediated Resistance to Imatinib Mesylate in Gastrointestinal Stromal Tumor
por: Rink, Lori, et al.
Publicado: (2013) -
Optimal Duration of Imatinib Mesylate Therapy in Metastatic Gastrointestinal Stromal Tumours
por: Gauden, Ruth, et al.
Publicado: (2011) -
Complete pathological response to Imatinib mesylate in an extraintestinal gastrointestinal stromal tumor
por: Quezada, Nicolás, et al.
Publicado: (2014)